COMMUNIQUÉS West-GlobeNewswire

-
Notice on additional agenda items for Extraordinary General Meeting of shareholders of Joint Stock Company Olainfarm to be held on November 1th, 2019 at 11:00
04/09/2019 -
EssilorLuxottica: Disclosure of Share Capital and Voting Rights Outstanding as of August 31, 2019
04/09/2019 -
EssilorLuxottica : Nombre total de droits de vote et d’actions composant le capital social au 31 août 2019
04/09/2019 -
Inventiva achieves a major milestone by completing patient recruitment for its Phase IIb clinical study with lanifibranor in NASH
04/09/2019 -
Inventiva franchit une étape clé avec la fin du recrutement des patients dans son étude clinique de Phase IIb avec lanifibranor dans la NASH
04/09/2019 -
Nicox confirme son éligibilité au PEA-PME
04/09/2019 -
CORRECTION - Centrexion Therapeutics
04/09/2019 -
PCI Biotech: Exercise of employee share options, mandatory notification of trade and resolution to increase share capital
04/09/2019 -
Emerald Health Therapeutics annonce un accord d'approvisionnement en cannabis de Pure Sunfarms avec la British Columbia Liquor Distribution Branch
04/09/2019 -
Roots of Hope national suicide prevention project to be launched in Ottawa on September 5, 2019
04/09/2019 -
Lancement le 5 septembre 2019 à Ottawa du projet national de prévention du suicide « Enraciner l’espoir »
04/09/2019 -
Las Vegas Tech Company Launches Downtown Coworking Space Cannabis Business Den
04/09/2019 -
JDRF Brings Together Hamilton Community, Researcher, and Elected Officials to Discuss Affordable Access to Life-Changing Technologies for type 1 diabetes
04/09/2019 -
INmune Bio Inc. to Introduce NeuLiv™ Program for Treatment of NASH at H.C. Wainwright 21st Annual Global Investment Conference
04/09/2019 -
Seelos Therapeutics to Participate in Upcoming Investor Conference in September
04/09/2019 -
Chiesi and Durham Bulls Partnership Culminates in $15,000 to Triangle Nonprofits
04/09/2019 -
Acasti Pharma to Present at the 21st Annual Rodman & Renshaw Global Investment Conference in New York City on September 9th
04/09/2019 -
Denali Therapeutics Announces First Patient Dosed in Phase 1b Study of DNL151 for Parkinson’s Disease and Launch of Its Engage Parkinson’s Website
04/09/2019 -
Ozop Surgical Corp. Announces Addition of Spine Industry Veteran to Lead its Sales Team
04/09/2019
Pages